Current Drug Discovery Technologies This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts
CONCLUSION: Benzene-1,2,4,5-tetramethyl from JGE extracts exhibited the most promising antidiabetic potential in-silico, suggesting its candidature as diabetes-target-protein inhibitor which may be developed for the treatment of type-2 diabetes mellitus.PMID:37817655 | DOI:10.2174/0115701638267143230925172207 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Olasunkanmi Kayode Awote Rahmon Ilesanmi Kanmodi Success Chidera Ebube Zainab Folashade Abdulganniyyu Source Type: research
Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts
CONCLUSION: Benzene-1,2,4,5-tetramethyl from JGE extracts exhibited the most promising antidiabetic potential in-silico, suggesting its candidature as diabetes-target-protein inhibitor which may be developed for the treatment of type-2 diabetes mellitus.PMID:37817655 | DOI:10.2174/0115701638267143230925172207 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Olasunkanmi Kayode Awote Rahmon Ilesanmi Kanmodi Success Chidera Ebube Zainab Folashade Abdulganniyyu Source Type: research
Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts
CONCLUSION: Benzene-1,2,4,5-tetramethyl from JGE extracts exhibited the most promising antidiabetic potential in-silico, suggesting its candidature as diabetes-target-protein inhibitor which may be developed for the treatment of type-2 diabetes mellitus.PMID:37817655 | DOI:10.2174/0115701638267143230925172207 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Olasunkanmi Kayode Awote Rahmon Ilesanmi Kanmodi Success Chidera Ebube Zainab Folashade Abdulganniyyu Source Type: research
Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts
CONCLUSION: Benzene-1,2,4,5-tetramethyl from JGE extracts exhibited the most promising antidiabetic potential in-silico, suggesting its candidature as diabetes-target-protein inhibitor which may be developed for the treatment of type-2 diabetes mellitus.PMID:37817655 | DOI:10.2174/0115701638267143230925172207 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Olasunkanmi Kayode Awote Rahmon Ilesanmi Kanmodi Success Chidera Ebube Zainab Folashade Abdulganniyyu Source Type: research
Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts
CONCLUSION: Benzene-1,2,4,5-tetramethyl from JGE extracts exhibited the most promising antidiabetic potential in-silico, suggesting its candidature as diabetes-target-protein inhibitor which may be developed for the treatment of type-2 diabetes mellitus.PMID:37817655 | DOI:10.2174/0115701638267143230925172207 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Olasunkanmi Kayode Awote Rahmon Ilesanmi Kanmodi Success Chidera Ebube Zainab Folashade Abdulganniyyu Source Type: research
Nutritional Profile, GC-MS Analysis and In-silico Anti-diabetic Phytocompounds Candidature of Jatropha gossypifolia Leaf Extracts
CONCLUSION: Benzene-1,2,4,5-tetramethyl from JGE extracts exhibited the most promising antidiabetic potential in-silico, suggesting its candidature as diabetes-target-protein inhibitor which may be developed for the treatment of type-2 diabetes mellitus.PMID:37817655 | DOI:10.2174/0115701638267143230925172207 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 11, 2023 Category: Drugs & Pharmacology Authors: Olasunkanmi Kayode Awote Rahmon Ilesanmi Kanmodi Success Chidera Ebube Zainab Folashade Abdulganniyyu Source Type: research
Development and In vitro Evaluation of Aceclofenac Buccal Film
CONCLUSION: Buccal films can be formulated using different polymers either individually or in combination to obtain the drug release profile required to achieve a desired treatment goal. Furthermore, the property of the buccal films depends on the type and concentration of the polymer used.PMID:37807409 | DOI:10.2174/0115701638262447230920061222 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 9, 2023 Category: Drugs & Pharmacology Authors: Samah Hamed Almurisi Ayah Mohammed Farah Qassem Heba Jehad Asma Jassim Khater Ahmed Saeed Al-JapairaI Rana Sammour Source Type: research
Development and In vitro Evaluation of Aceclofenac Buccal Film
CONCLUSION: Buccal films can be formulated using different polymers either individually or in combination to obtain the drug release profile required to achieve a desired treatment goal. Furthermore, the property of the buccal films depends on the type and concentration of the polymer used.PMID:37807409 | DOI:10.2174/0115701638262447230920061222 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 9, 2023 Category: Drugs & Pharmacology Authors: Samah Hamed Almurisi Ayah Mohammed Farah Qassem Heba Jehad Asma Jassim Khater Ahmed Saeed Al-JapairaI Rana Sammour Source Type: research
Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant Acinetobacter baumannii Clinical Isolates
CONCLUSION: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.PMID:37779401 | DOI:10.2174/0115701638253395230919112548 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 2, 2023 Category: Drugs & Pharmacology Authors: Iraj Pakzad Fatemeh Yarkarami Behrooz Sadeghi Kalani Mahnaz Shafieian Ali Hematian Source Type: research
Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant Acinetobacter baumannii Clinical Isolates
CONCLUSION: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.PMID:37779401 | DOI:10.2174/0115701638253395230919112548 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 2, 2023 Category: Drugs & Pharmacology Authors: Iraj Pakzad Fatemeh Yarkarami Behrooz Sadeghi Kalani Mahnaz Shafieian Ali Hematian Source Type: research
Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant Acinetobacter baumannii Clinical Isolates
CONCLUSION: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.PMID:37779401 | DOI:10.2174/0115701638253395230919112548 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 2, 2023 Category: Drugs & Pharmacology Authors: Iraj Pakzad Fatemeh Yarkarami Behrooz Sadeghi Kalani Mahnaz Shafieian Ali Hematian Source Type: research
Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant Acinetobacter baumannii Clinical Isolates
CONCLUSION: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.PMID:37779401 | DOI:10.2174/0115701638253395230919112548 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 2, 2023 Category: Drugs & Pharmacology Authors: Iraj Pakzad Fatemeh Yarkarami Behrooz Sadeghi Kalani Mahnaz Shafieian Ali Hematian Source Type: research
Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant Acinetobacter baumannii Clinical Isolates
CONCLUSION: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.PMID:37779401 | DOI:10.2174/0115701638253395230919112548 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 2, 2023 Category: Drugs & Pharmacology Authors: Iraj Pakzad Fatemeh Yarkarami Behrooz Sadeghi Kalani Mahnaz Shafieian Ali Hematian Source Type: research
Inhibitory Effects of Carvacrol on Biofilm Formation in Colistin Heteroresistant Acinetobacter baumannii Clinical Isolates
CONCLUSION: The results of this study showed that sub-MIC of Carvacrol has anti-biofilm effects in clinical A.baumannii colistin hetero-resistance isolates.PMID:37779401 | DOI:10.2174/0115701638253395230919112548 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - October 2, 2023 Category: Drugs & Pharmacology Authors: Iraj Pakzad Fatemeh Yarkarami Behrooz Sadeghi Kalani Mahnaz Shafieian Ali Hematian Source Type: research
Computational Studies and Synthesis of New Heterocyclics as CNS Agents
CONCLUSION: The designed scheme was executed in the departmental laboratory. The chemical structure of the compounds was confirmed on the basis of TLC, IR, and 1HNMR analyses. The docking study revealed a good docking score of the compounds. The Log P value of the compounds indicated their good penetration into CNS. The compounds were also screened for anxiolytic activity. Among them, compounds 4f, 4h, and P3 showed maximum activity as anti-anxiolytic agents.PMID:37723630 | DOI:10.2174/1570163820666230918100218 (Source: Current Drug Discovery Technologies)
Source: Current Drug Discovery Technologies - September 19, 2023 Category: Drugs & Pharmacology Authors: Pooja Saini Sushil Kumar Source Type: research